Gadoteridol Injection Solution Articles
Bracco and Health Trust in contrast media deal
15 October 2007
FDA call for warning on contrast agents
4 June 2007
Bracco and AmeriNet expand deal on contrast agents
24 February 2003
Eisai And B-MS To Copromote ProHance
17 July 1995
PROHANCE IN JAPAN
28 February 1994
JAPAN NEWS IN BRIEF
10 January 1994
PENDING APPLICATIONS IN US CONTINUE TO DWINDLE
19 July 1993
SIGNIFICANT MOVES BY PHARMA COS IN FT 500
1 March 1993
PROHANCE LAUNCH
22 February 1993
FDA APPROVES 26 NEWDRUGS IN 1992
25 January 1993
HAFSLUND NYCOMED DOWNGRADED
7 December 1992
CONTRAST MEDIA MARKET SLOWDOWN EXPLAINED
7 December 1992
B-MS' PROHANCE APPROVED IN USA
7 December 1992
STRONG INCREASES IN 1991 AT BRISTOL-MYERS SQUIBB
20 April 1992
Showing 1-14 of 14 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
